Literature DB >> 22750268

Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells.

Jin-Qiang Chen1, Jose Russo.   

Abstract

A common set of functional characteristics of cancer cells is that cancer cells consume a large amount of glucose, maintain high rate of glycolysis and convert a majority of glucose into lactic acid even in the presence of oxygen compared to that of normal cells (Warburg's Effects). In addition, cancer cells exhibit substantial alterations in several energy metabolism pathways including glucose transport, tricarboxylic acid (TCA) cycle, glutaminolysis, mitochondrial respiratory chain oxidative phosphorylation and pentose phosphate pathway (PPP). In the present work, we focused on reviewing the current knowledge about the dysregulation of the proteins/enzymes involved in the key regulatory steps of glucose transport, glycolysis, TCA cycle and glutaminolysis by several oncogenes including c-Myc and hypoxia inducible factor-1 (HIF-1) and tumor suppressor, p53, in cancer cells. The dysregulation of glucose transport and energy metabolism pathways by oncogenes and lost functions of the tumor suppressors have been implicated as important biomarkers for cancer detection and as valuable targets for the development of new anticancer therapies.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22750268     DOI: 10.1016/j.bbcan.2012.06.004

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  115 in total

1.  TRIM24 links glucose metabolism with transformation of human mammary epithelial cells.

Authors:  T N Pathiraja; K N Thakkar; S Jiang; S Stratton; Z Liu; M Gagea; X Shi; P K Shah; L Phan; M-H Lee; J Andersen; M Stampfer; M C Barton
Journal:  Oncogene       Date:  2014-07-28       Impact factor: 9.867

Review 2.  How do glycolytic enzymes favour cancer cell proliferation by nonmetabolic functions?

Authors:  H Lincet; P Icard
Journal:  Oncogene       Date:  2014-09-29       Impact factor: 9.867

3.  miR-290/371-Mbd2-Myc circuit regulates glycolytic metabolism to promote pluripotency.

Authors:  Yang Cao; Wen-Ting Guo; Shengya Tian; Xiaoping He; Xi-Wen Wang; Xiaomeng Liu; Kai-Li Gu; Xiaoyu Ma; De Huang; Lan Hu; Yongping Cai; Huafeng Zhang; Yangming Wang; Ping Gao
Journal:  EMBO J       Date:  2015-01-20       Impact factor: 11.598

4.  FOXM1 promotes the warburg effect and pancreatic cancer progression via transactivation of LDHA expression.

Authors:  Jiujie Cui; Min Shi; Dacheng Xie; Daoyan Wei; Zhiliang Jia; Shaojiang Zheng; Yong Gao; Suyun Huang; Keping Xie
Journal:  Clin Cancer Res       Date:  2014-03-14       Impact factor: 12.531

5.  Glucose modulation induces reactive oxygen species and increases P-glycoprotein-mediated multidrug resistance to chemotherapeutics.

Authors:  N A Seebacher; D R Richardson; P J Jansson
Journal:  Br J Pharmacol       Date:  2015-03-17       Impact factor: 8.739

Review 6.  MUC1: a novel metabolic master regulator.

Authors:  Kamiya Mehla; Pankaj K Singh
Journal:  Biochim Biophys Acta       Date:  2014-01-11

Review 7.  Metabolism and immunity in breast cancer.

Authors:  Deyu Zhang; Xiaojie Xu; Qinong Ye
Journal:  Front Med       Date:  2020-10-19       Impact factor: 4.592

8.  Increased sensitivity to glucose starvation correlates with downregulation of glycogen phosphorylase isoform PYGB in tumor cell lines resistant to 2-deoxy-D-glucose.

Authors:  Katherine B Philips; Metin Kurtoglu; Howard J Leung; Huaping Liu; Ningguo Gao; Mark A Lehrman; Timothy G Murray; Theodore J Lampidis
Journal:  Cancer Chemother Pharmacol       Date:  2013-12-01       Impact factor: 3.333

Review 9.  Integrating canonical and metabolic signalling programmes in the regulation of T cell responses.

Authors:  Kristen N Pollizzi; Jonathan D Powell
Journal:  Nat Rev Immunol       Date:  2014-07       Impact factor: 53.106

10.  Resistance to chemotherapy is associated with altered glucose metabolism in acute myeloid leukemia.

Authors:  Kui Song; Min Li; Xiaojun Xu; L I Xuan; Guinian Huang; Qifa Liu
Journal:  Oncol Lett       Date:  2016-05-17       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.